- Login
- Register
- Home/Current Issue
- About the journal
- Editorial board
- Online submission
- Instructions for authors
- Subscriptions
- Foundation Acta Endocrinologica
- Archive
- Contact
Romanian Academy
The Publishing House of the Romanian Academy
ACTA ENDOCRINOLOGICA (BUC)
The International Journal of Romanian Society of Endocrinology / Registered in 1938in Web of Science Master Journal List
Acta Endocrinologica(Bucharest) is live in PubMed Central
Journal Impact Factor - click here.
This Article
Services
Google Scholar
PubMed
Acta Endocrinologica (Buc)
Aydin C, Ersoy R, Ozdemir D, Cuhaci N, Arpaci D, Usluogullari CA, Ustu Y, Baser H, Dirikoc A, Cakir B
Comparison of Growth Hormone Suppression Response after Oral and Intravenous Glucose Tolerance Tests in Healthy Adults
Acta Endo (Buc) 2015, 11 (2): 202-207doi: 10.4183/aeb.2015.202
Objective. Personal discrepancies in gastrointestinal
physiology might influence responses to GH suppression
during OGTT. We aim to compare growth hormone (GH)
response during oral glucose tolerance test (OGTT) and
intravenous glucose tolerance test (IVGTT).
Methods. Data of 18 healthy volunteers were
analyzed in the study. Subjects were firstly evaluated with
standard 75-g OGTT. In subjects with serum glucose <100
mg/dL at basal state and <140 mg/dL at 120th minute of oral
loading, IVGTT was performed after at least 3 days. Serum
glucose, insulin and GH levels were measured during two
tests.
Results. Basal GH levels had a wide distribution
ranging from 0.00005 μg/L to 0.768 μg/L (median 0.0145
μg/L). Mean nadir GH level during OGTT was obtained at
60th minute and it was 0.0376 μg/L(range 0.00011-0.387,
median 0.0016 μg/L, SD: 0.095, SEM: 0.038). Nadir GH
level during IVGTT was observed at 10th minute and it was
0.112 μg/L(range 0.0005-0.770 μg/L, median 0.0053 μg/L,
SD: 0.242, SEM: 0.057). There was a statistically significant
difference between nadir GH levels obtained during IVGTT
and OGTT (p=0.028).
Conclusions. We found that mean nadir GH level
was significantly higher during IVGTT in healthy subjects.
This is a preliminary study and further large scale studies are
required to suggest that IVGTT may be used in the diagnosis
and follow-up of patients with acromegaly as an alternative
to or instead of OGTT.
Keywords: Growth hormone, oral glucose tolerance test, intravenous glucose tolerance test.
Correspondence: Reyhan Ersoy MD, Yildirim Beyazit University, Faculty of Medicine, Department of Endocrinology and Metabolism Lodumlu Mevkii, Bilkent Yolu No 2, Ankara, 06800, Turkey, E-mail: reyhanersoy@yahoo.com.tr